Sanofi announces positive Phase 3 results for investigational new insulin U300
Topline results of EDITION II consistent with EDITION I findings...
22 June 2013 | By Sanofi
Topline results of EDITION II consistent with EDITION I findings...
List view / Grid view
Topline results of EDITION II consistent with EDITION I findings...
22 June 2013 | By Sanofi
Topline results of EDITION II consistent with EDITION I findings...
New data from ORIGIN shows Lantus® use is about 3…
5 October 2012 | By Sanofi
New data from ORIGIN shows Lantus® use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population...
Data from phase III GetGoal Duo 1 study...
6 December 2011 | By Sanofi
Data from phase III GetGoal Duo 1 study...